3N6
N-{(1S)-5-amino-1-[(4-pyridin-4-ylpiperazin-1-yl)carbonyl]pentyl}-3,5-dibromo-Nalpha-{[4-(2-oxo-1,4-dihydroquinazolin-3 (2H)-yl)piperidin-1-yl]carbonyl}-D-tyrosinamide
Find entries where: 3N6
is present as a standalone ligand in 3 entries
Chemical Component Summary | |
---|---|
Name | N-{(1S)-5-amino-1-[(4-pyridin-4-ylpiperazin-1-yl)carbonyl]pentyl}-3,5-dibromo-Nalpha-{[4-(2-oxo-1,4-dihydroquinazolin-3 (2H)-yl)piperidin-1-yl]carbonyl}-D-tyrosinamide |
Synonyms | Olcegepant |
Identifiers | N-[(2R)-1-[[(2S)-6-azanyl-1-oxo-1-(4-pyridin-4-ylpiperazin-1-yl)hexan-2-yl]amino]-3-(3,5-dibromo-4-hydroxy-phenyl)-1-oxo-propan-2-yl]-4-(2-oxo-1,4-dihydroquinazolin-3-yl)piperidine-1-carboxamide |
Formula | C38 H47 Br2 N9 O5 |
Molecular Weight | 869.645 |
Type | NON-POLYMER |
Isomeric SMILES | c1ccc2c(c1)CN(C(=O)N2)C3CCN(CC3)C(=O)N[C@H](Cc4cc(c(c(c4)Br)O)Br)C(=O)N[C@@H](CCCCN)C(=O)N5CCN(CC5)c6ccncc6 |
InChI | InChI=1S/C38H47Br2N9O5/c39-29-21-25(22-30(40)34(29)50)23-33(45-37(53)48-15-10-28(11-16-48)49-24-26-5-1-2-6-31(26)44-38(49)54)35(51)43-32(7-3-4-12-41)36(52)47-19-17-46(18-20-47)27-8-13-42-14-9-27/h1-2,5-6,8-9,13-14,21-22,28,32-33,50H,3-4,7,10-12,15-20,23-24,41H2,(H,43,51)(H,44,54)(H,45,53)/t32-,33+/m0/s1 |
InChIKey | ITIXDWVDFFXNEG-JHOUSYSJSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 101 |
Chiral Atom Count | 2 |
Bond Count | 106 |
Aromatic Bond Count | 18 |
Drug Info: DrugBank
DrugBank ID | DB04869Â |
---|---|
Name | Olcegepant |
Groups | investigational |
Description | Boehringer Ingelheim Pharmaceuticals’ olcegepant (BIBN 4096) is a selective Calcitonin Gene-Related Peptide (CGRP) antagonist, a new class of drugs in development for the treatment of acute migraine attacks. Olcegepant is undergoing phase II trials in Europe and the US, with preliminary results suggesting that CGRP antagonists may represent a potential new approach to the treatment of migraine. |
Synonyms | Olcegepant |
Indication | For the treatment of migraine headaches. |
Categories |
|
CAS number | 204697-65-4 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Calcitonin gene-related peptide type 1 receptor | MEKKCTLNFLVLLPFFMILVTAELEESPEDSIQLGVTRNKIMTAQYECYQ... | unknown | antagonist |
Calcitonin gene-related peptide 1 | MGFQKFSPFLALSILVLLQAGSLHAAPFRSALESSPADPATLSEDEARLL... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL207197 |
PubChem | 6918509 |
ChEMBL | CHEMBL207197 |